800 SUSTAINED VIROLOGIC RESPONSE TO INTERFERON ALFA-2B PLUS RIBAVIRIN PREDICTS LONG-TERM CLEARANCE OF HCV IN PEDIATRIC PATIENTS AT 5 YEAR FOLLOW-UP